The U.S. Food and Drug Administration (FDA) announced the recall of three epinephrine lots, used to treat severe allergic reactions, after consumer complaints.
According to an announcement on Jan. 9, manufacturer Spectrum Laboratory Products said it voluntarily recalled the lots after the product was found to be discolored.
Epinephrine, known as L-adrenaline USP, is a bulk active pharmaceutical ingredient that can “treat a variety of medical conditions including anaphylaxis and other severe immediate hypersensitivity reactions, asthma, bronchospasm, airway edema, nasal congestion, dilation during intraocular surgery, vasoconstrictor with local anesthetics, hypotension or shock, heart failure, bradycardia or atrioventricular block, and sudden cardiac arrest,” the announcement said….